In RCC, abnormal activation of the PI3K/AKT/mTOR signaling pathway is highly prevalent,31 with extracellular signaling molecules and transmembrane receptors playing a pivotal role in initiating the activation of this pathway. Here, MTOR is linked to renal cell carcinoma.